Featured News
Danaher Reports First Quarter 2025 Results
Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended March 28, 2025.
Press Releases
Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine
Danaher has entered a partnership with AstraZeneca to scale precision medicine, including developing the next generation of AI-powered diagnostics This partnership aims to create a framework for...
05.29.2025
Danaher to Present at Bank of America Securities Healthcare Conference
Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the at the Bank of America Securities Health Care Conference in Las...
05.07.2025
Danaher Announces Quarterly Dividend
Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on July 25, 2025 to...
05.06.2025
Resources
Stay informed with the latest in Danaher media coverage.
Looking for Danaher media assets? The media center offers brand assets and other media approved for public use—all high quality and ready to download.